This was the stock's second consecutive day of losses.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Humana, the second-largest Medicare Advantage insurer in the country, is turning to a familiar strategy to boost ...

Top officials in the Department of Health and Human Services are touting a multi-pronged effort from major payers to reform ...

Health insurers accounting for roughly 75% of U.S. patients signed an industry-led pledge this week for improving patient ...

At the insurer's investor day, Humana struck a middle ground in defending the importance of the privatized Medicare program — ...

Humana leaders asserted at the company’s investor day Monday that there’s still money to be made on Medicare Advantage ...

UnitedHealthcare, Blue Cross Blue Shield and other health insurers plan fixes to prioer authorization, a common source of consumer complaints.

This was the stock's fourth consecutive day of gains.

Truist Financial analyst David S Macdonald maintained a Hold rating on Humana (HUM – Research Report) today. The company’s shares closed yesterday at $235.39. Confident Invest ...

In a report released today, Ann Hynes from Mizuho Securities reiterated a Buy rating on Humana (HUM – Research Report), with a price target of $316.00. The company’s shares op ...

Major American insurers announced Monday that they have agreed to speed up and smooth out the processes involved with the ...